DOI:
10.1055/s-00000075
Seminars in Respiratory and Critical Care Medicine
LinksClose Window
References
Glanville AR, Scott AI, Morton JM. et al.
Intravenous ribavirin is a safe and cost-effective treatment for respiratory syncytial virus infection after lung transplantation.
J Heart Lung Transplant 2005;
24 (12) 2114-2119
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.